SERPINE1 and endothelial dysfunction: These results, combined with those of VCAM-1 and PAI-1, could suggest that a longer period of administration may be necessary to have an effect on circulating biomarkers of oxidative stress and endothelial dysfunction in untreated subjects with mild cardiometabolic alterations.